Our Vision

The Better Pharmacare Coalition works on behalf of its
members to ensure appropriate and timely BC PharmaCare program
coverage for evidence-based prescription medications and health products.
Poll reveals opposition to expansion of Reference Drug Program
Cabinet recently approved amendments to the Drug Price Regulation that serve to create the three new reference drug categories. Angiotensin Receptor Blocker, Proton Pump Inhibitor and Statin reference categories are now in the regulations with specific product designations to be added in the spring. The specific product designations for the three categories to be modified - Angiotensin Converting Enzyme Inhibitors, Calcium Channel Blockers and H2 Blockers - will also be finalized in the next few months.

BC PharmaCare has informed us that input and feedback from all of its initial stakeholder sessions has been compiled and reviewed and they have made a few modifications to their timeline as well as their approach. The timeline for transitioning patients will now be from June 1, 2016 through the end of November. On December 1, 2016 the new policy will be in effect. PharmaCare claims to have also paid close attention to patients that may be at risk should change of medication be contemplated.

The BPC cautioned the government from the outset that the unilateral decisions made by the Ministry of Health to expand the Reference Drug Program (RDP), without any meaningful consultation with our BPC membership, would result in policy expansion that has the potential to harm individual patients and patient care, and would ultimately be detrimental for the residents of British Columbia.

Moving Forward
BPC has sought out the opinion of British Columbians on BC PharmaCare's RDP, one of two cohorts comprising those living with a chronic disease. Based on the poll results, BPC is encouraging its members to raise awareness and generate media coverage and social media "buzz" among the 19 BPC member communities (representing 2 million patients) and inform influential MLAs, Cabinet Ministers and Premiers Office staff that the Ministry of Health has enacted regulation change that raises the spectre of harm for patients and is "bad politics" for government at the start of the re–election cycle.

If you, or a loved one that you care for, have experienced an access to medication issue, please share your story with us.

Your Stories

Article 1: Catch 22 plus 40
Allan suffers from a rare disease called Idiopathic Thrombocytopenic Purpura (ITP). Without treatment he could die in pretty short order {more)...
What's New
February 12, 2016
British Columbians' grave concerns over expansion of BC government's Reference Drug Program

February 9, 2016
Better Pharmacare Coalition poll reveals British Columbians oppose changes to planned expansion to BC government's Reference Drug Program

November 28, 2013
Canadian PKU & Allied Disorders Inc. Announces B.C.'s decision to fund medical foods to protect against brain-threatening disease

November 24, 2013
Bulk Drug Purchasing Is Too Good to Be True

August 13, 2013
Tread carefully on bulk drug purchases

August 9, 2013
Pharmacare no panacea for health care costs

May 12, 2013
Liberal Party of BC Response

May 7, 2013
Green Party of BC Response

May 7, 2013
New Democratic Party of BC Response

April 19, 2013
BPC letter to candidates

April 19, 2013
BPC survey for candidates

BPC Members
The BPC is an alliance of provincial and national not-for-profit organizations. More on our members.

Visit Our Twitter account